Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Operating activities
Net (loss) income from continuing operations	$ (32,033)	$ 3,109
Adjustments to reconcile net (loss) income to net cash used in operating activities
Non-cash write downs of inventory	1,081	8,495
Accretion expense	5,673	1,708
Depreciation of property and equipment and amortization of intangible assets	9,761	11,253
Amortization of operating right-of-use assets	932	1,074
Share-based compensation	3,694	7,819
Deferred income tax expense	815	(787)
Gain on fair value of warrants and purchase option derivative	(653)	(53,058)
Loss on disposal of fixed assets	345	929
Revaluation of contingent consideration		153
Release of indemnification asset		3,973
Unrealized and realized foreign exchange (gain) loss	(132)	41
Unrealized and realized loss on investments / derivatives	2,410	234
Changes in operating assets and liabilities
Receivables	295	(445)
Inventory	(7,851)	208
Prepaid expense and other current assets	(319)	1,434
Deposits	431	206
Other assets	714	461
Accounts payable and accrued liabilities and other payables	4,089	(7,840)
Operating lease liability	(337)	(614)
Other liability	1,085	(10,353)
Contingent consideration payable		(410)
Corporate income tax payable	22,127	5
Deferred revenue	157	766
Net cash provided by (used in) operating activities- continuing operations	12,284	(31,639)
Net cash (used in) operating activities- discontinued operations	(3,164)	(3,337)
Net cash provided by (used in) operating activities	9,120	(34,976)
Investing activities
Investment in property and equipment	(4,504)	(12,500)
Investment in intangible assets	(262)	(1,330)
Principal payments received on lease receivable	104	392
Receipt of convertible debenture payment	738
Deposits for property and equipment		(10,036)
Deposits for business acquisition		(852)
Payment for land contracts	(769)	(429)
Cash portion of consideration paid in acquisitions, net of cash of acquired	(14,469)	24,716
Net cash (used in) / provided by investing activities- continuing operations	(19,162)	(39)
Net cash (used in) /provided by investing activities- discontinued operations	14,285
Net cash (used in) / provided by investing activities	(4,877)	(39)
Financing activities
Transfer of Employee Retention Credit	12,677
Proceeds from loan payable, net of transaction costs	23,872
Proceeds from options and warrants exercised	81	24,158
Loan principal paid	(40,359)	(4,968)
Loan amendment fee paid and prepayment premium paid	(1,178)	(1,200)
Cash distributions to partners	(3,415)	(1,436)
Capital contributions paid to non-controlling interests		(448)
Payments of contingent consideration		(6,630)
Proceeds from private placement, net of share issuance costs	19,218
Payments made for financing obligations and finance lease	(941)	(460)
Net cash provided by financing activities- continuing operations	9,955	9,016
Net cash provided by financing activities- discontinued operations	(5,539)	(235)
Net cash (used in) /provided by financing activities	4,416	8,781
Net increase in cash and cash equivalents and restricted cash during the period	8,659	(26,234)
Net effects of foreign exchange	(901)	(4,377)
Cash and cash equivalents and restricted cash, beginning of the period	26,763	79,642
Cash and cash equivalents and restricted cash, end of the period	34,521	49,031
Supplemental disclosure with respect to cash flows
Income taxes (refund received) paid	(4,582)	9,213
Interest paid	9,259	14,641
Lease termination fee paid		3,300
Non-cash transactions
Equity and warrant liability issued as consideration for acquisition	10,267	294,800
Shares issued for legal and liability settlement	794	22
Accrued capital purchases	$ 529	$ 9,776